Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Checkpoint Therapeutics, Inc. CKPT
$2.73
-$0.06 (-2.15%)
На 18:00, 12 мая 2023
+632.60%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
41855586.00000000
-
week52high
14.90
-
week52low
1.84
-
Revenue
192000
-
P/E TTM
0
-
Beta
1.44325200
-
EPS
-6.53000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 20:00
Описание компании
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302, a human agonistic antibody that is designed to bind to and trigger signaling in GITR expressing cells. It is also developing Olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a treatment for patients with EGFR mutation-positive non-small cell lung cancer; CK-103, a selective and potent small molecule inhibitor of bromodomain and extra-terminal bromodomains; and anti-carbonic anhydrase IX (CAIX) antibody, a fully human preclinical antibody to recognize CAIX expressing cells and kill them via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. The company has collaboration agreements with TG Therapeutics, Inc. to develop and commercialize certain assets in connection with its licenses in the field of hematological malignancies. The company was incorporated in 2014 and is based in Waltham, Massachusetts. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 25 янв 2022 г. |
| B. Riley Securities | Buy | 09 июн 2021 г. | |
| Cantor Fitzgerald | Overweight | 20 янв 2021 г. | |
| HC Wainwright & Co. | Buy | Buy | 29 сент 2020 г. |
| H.C. Wainwright | Buy | 08 дек 2017 г. | |
| HC Wainwright & Co. | Buy | Buy | 23 дек 2022 г. |
| B. Riley Securities | Buy | Buy | 19 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Oliviero James F III | D | 182121 | 10261 | 01 февр 2023 г. |
| GRAY WILLIAM GARRETT | D | 49379 | 3154 | 01 февр 2023 г. |
| Oliviero James F III | D | 192382 | 3817 | 10 янв 2023 г. |
| GRAY WILLIAM GARRETT | D | 52533 | 1858 | 10 янв 2023 г. |
| Fortress Biotech, Inc. | A | 1503713 | 368907 | 05 янв 2023 г. |
| Oliviero James F III | D | 196199 | 60000 | 26 сент 2022 г. |
| Oliviero James F III | D | 2562003 | 15000 | 23 июн 2022 г. |
| Oliviero James F III | D | 2577003 | 12000 | 22 июн 2022 г. |
| Oliviero James F III | D | 2589003 | 21000 | 21 июн 2022 г. |
| Oliviero James F III | D | 2610003 | 228000 | 17 июн 2022 г. |
Новостная лента
3 Penny Stocks That Could Make You a Millionaire by 2025
InvestorPlace
11 мая 2023 г. в 16:40
Penny stocks have had a great start this year, but with uncertainty starting to rear its head again, investors have started to choose safer options instead. Indeed, the underlying businesses of most penny stocks are loss-making startups that depend on external sources to survive in the long run.
Checkpoint Therapeutics: An Updated Analysis
Seeking Alpha
10 янв 2023 г. в 13:40
We are checking back in on a small developmental company called Checkpoint Therapeutics, Inc. The company is planning to submit a BLA targeting two indications for its lead product candidate cosibelimab later this month.
5 Penny Stocks With Explosive Price Targets & Buy Ratings From Analysts
PennyStocks
27 дек 2022 г. в 13:52
Analysts Say These Are Penny Stocks To Buy But Are They Worth The Risk? The post 5 Penny Stocks With Explosive Price Targets & Buy Ratings From Analysts appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Wedbush's Dan Ives offers his bullish outlook on tech in 2023
CNBC Television
12 дек 2022 г. в 18:28
Dan Ives, Wedbush analyst, joins 'Closing Bell: Overtime' to discuss why he believes there will be a tech rebound.
Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences
GlobeNewsWire
22 сент 2022 г. в 08:30
WALTHAM, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in two upcoming investor conferences. Details are as follows: